Patient’s Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective We aimed to identify the expectations and preferences for medication and medical decision-making in patients with major psychiatric disorders.Methods A survey was conducted among patients with major psychiatric disorders who visited psychiatric outpatient clinics at 15 hospitals between 2016 and 2018 in Korea. The survey consisted of 12 questions about demographic variables and opinions on their expectations for medication, important medical decision-makers, and preferred drug type. The most preferred value in each category in the total population was identified, and differences in the preference ratio of each item among the disease groups were compared.Results A total of 707 participants were surveyed. In the total population, patients reported high efficacy (44.01%±21.44%) as the main wish for medication, themselves (37.39%±22.57%) and a doctor (35.27%±22.88%) as the main decision makers, and tablet/capsule (36.16%±30.69%) as the preferred type of drug. In the depressive disorders group, the preference ratio of high efficacy was significantly lower, and the preference ratio of a small amount was significantly higher than that of the psychotic disorder and bipolar disorder groups. The preference ratio of a doctor as an important decision maker in the bipolar disorder group was higher compared to the other groups.Conclusion This study revealed the preference for medications and showed differences among patients with psychiatric disorders. Providing personalized medicine that considers a patient’s preference for the drug may contribute to the improvement of drug compliance and outcomes.
Abstract
Objective We aimed to identify the expectations and preferences for medication and medical decision-making in patients with major psychiatric disorders.Methods A survey was conducted among patients with major psychiatric disorders who visited psychiatric outpatient clinics at 15 hospitals between 2016 and 2018 in Korea. The survey consisted of 12 questions about demographic variables and opinions on their expectations for medication, important medical decision-makers, and preferred drug type. The most preferred value in each category in the total population was identified, and differences in the preference ratio of each item among the disease groups were compared.Results A total of 707 participants were surveyed. In the total population, patients reported high efficacy (44.01%±21.44%) as the main wish for medication, themselves (37.39%±22.57%) and a doctor (35.27%±22.88%) as the main decision makers, and tablet/capsule (36.16%±30.69%) as the preferred type of drug. In the depressive disorders group, the preference ratio of high efficacy was significantly lower, and the preference ratio of a small amount was significantly higher than that of the psychotic disorder and bipolar disorder groups. The preference ratio of a doctor as an important decision maker in the bipolar disorder group was higher compared to the other groups.Conclusion This study revealed the preference for medications and showed differences among patients with psychiatric disorders. Providing personalized medicine that considers a patient’s preference for the drug may contribute to the improvement of drug compliance and outcomes.
참고문헌 (23)
- Kaplan G, "Impact of long-acting injectable antipsy chotics on medication adherence and clinical, functional, and econom ic outcomes of schizophrenia", Patient Prefer Adherence, 7, pp.11711180~ (2013)
- Blackwell B, "Treatment adherence", Br J Psychiatry, 129, pp.513~531 (1976)
- Cramer JA, "Medication compliance and persistence : terminology and defini tions", Value Health, 11, pp.44~47 (2008)
- Cramer JA, "Compliance with medication regimens for mental and physical disorders", Psychiatr Serv, 49, pp.196~201 (1998)
- Sabaté E, "Adherence to long-term therapies : evidence for action" (2003), World Health Organization
- Park MC, "Psychodynamic approach for adherence", J Korean Soc Biol T her Psychiatry, 8, pp.40~45 (2002)
- Lacro JP, "Prevalence of and risk factors for medication nonadherence in patients with schizo phrenia : a comprehensive review of recent literature", J Clin Psychiatry, 63, pp.892~909 (2002)
- Lee MS, "Treatment compliance of antidepressants", Korean J Biol Psychiatry, 17, pp.5~14 (2010)
- Jawad I, "Medication nonadherence in bipolar disorder : a narrative review", Ther Adv Psychopharmacol, 8, pp.349~363 (2018)
- Sajatovic M, "Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder", J Affect Disord, 115, pp.360~366 (2009)
- Johnson FR, "Factors that affect adherence to bipolar disorder treatments : a stated-preference approach", Med Care, 45, pp.545~552 (2007)
- Guha M, "Diagnostic and statistical manual of mental disorders: DSM 5 (5th edition)", Ref Rev, 28, pp.36~37 (2014)
- Achtyes E, "Pa tient preferences concerning the efficacy and side-effect profile of schizophrenia medications : a survey of patients living with schizo phrenia", BMC Psychiatry, 18, pp.292~ (2018)
- Kikkert MJ, "Medication adherence in schizophrenia : exploring patients’, carers’and professionals’ views", Schizophr Bull, 32, pp.786~794 (2006)
- Srimongkon P, "Consumer-related factors influenc ing antidepressant adherence in unipolar depression : a qualitative study", Patient Prefer Adherence, 12, pp.1863~1873 (2018)
- Eisen SA, "The effect of prescribed daily dose frequency on patient medication com pliance", Arch Intern Med, 150, pp.1881~1884 (1990)
- Demyttenaere K, "Compliance during treatment with antidepressants", J Affect Disord, 43, pp.27~39 (1997)
- Adams JR, "Shared decision-making preferenc es of people with severe mental illness", Psychiatr Serv, 58, pp.12191221~ (2007)
- De Las Cuevas C, "To what extent is treatment ad herence of psychiatric patients influenced by their participation in shared decision making?", Patient Prefer Adherence, 8, pp.1547~1553 (2014)
- Lazary J, "Adherence to psychiatric medications : comparing patients with schizophrenia, bipolar disorder and major depression", Neuropsycho pharmacol Hung, 23, pp.363~373 (2021)
- Blackwood C, "Patients’ preference for long-acting injectable versus oral antipsy chotics in schizophrenia : results from the patient-reported medication preference questionnaire", Patient Prefer Adherence, 14, pp.1093~1102 (2020)
- Lee Y, "The preference survey for long-acting injectable antipsychotics of community-dwelling patients with schizophrenia and their caregivers", Korean J Schizophr Res, 16, pp.14~24 (2013)
- Carpenter WT Jr, "Decisional capacity for informed consent in schizophrenia re search", Arch Gen Psychiatry, 57, pp.533~538 (2000)